Yew Bio Pharm Revenue, Profits - YEWB Quarterly Income Statement

Add to My Stocks
$0.2 $0 (0%) YEWB stock closing price Sep 19, 2018 (Closing)

YEWB stock valuation based on fundamental analysis involves checking and analyzing financial statements and not just the Yew Bio Pharm stock price. In the income statement, an investor can check for important parameters like the topline or sales, the bottomline or profits, the basic EPS, dividends etc. When compared with the corresponding income statement from the past, the latest income statement shows how revenue has grown from 3.03M to 14.82M and how operating and non operating activities have impacted the YEWB stock. One also needs to look at Yew Bio Pharm assets, operating expenses and Yew Bio Pharm free cash flow. The Yew Bio Pharm profit and loss statement shows revenue of $14.82M for 2018 Q2. Revenue has grown by 389.11% QoQ for YEWB stock.

View and download details of revenue and profits for Yew Bio Pharm for latest & last 40 quarters.
show more
Quarterly
Annual
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q1
Yew Bio Pharm Revenues or Net Sales
14.82M3.03M5.5M11.57M15.6M7.88M12M14.67M16.06M8.62M
Cost Of Goods Sold (COGS)11.47M2.55M12.3M10.81M5.01M7.35M13.24M13.24M14.41M7.22M
Yew Bio Pharm Gross Profit
3.35M--6.77M-10.58M--1.21M1.41M1.64M1.39M
Research & Development Expense----------
Selling General & Admin Expense1.29M---------
Income Before Depreciation Depletion Amortization2.07M--7.66M-10.28M--1.36M1.11M1.3M1.07M
Depreciation Depletion Amortization----------
Non Operating Income-0.45M-0.07M-0.15M--0.03M-0.05M-0.04M-0.03M--0.02M
Interest Expense----------
Yew Bio Pharm Pretax Income
1.61M--7.81M-10.25M--1.41M1.08M1.3M1.05M
Provision for Income Taxes----------
MinorityInterest----------
Investment Gains Losses----------
Other Income----------
Income Before Extraordinaries & Disc Operations1.61M--7.83M-10.26M--1.43M1.08M1.31M1.05M
Extraordinary Items & Discontinued Operations----------
Yew Bio Pharm Profit/ Loss (Net Income)
1.61M--7.83M-10.26M--1.43M1.08M1.31M1.05M
Average Shares used to compute Diluted EPS55.87M60.09M53.98M54.56M53.04M56.67M51.88M51.89M51.88M51.88M
Average Shares used to compute Basic EPS51.88M51.88M53.98M51.88M51.88M51.88M51.88M51.88M51.88M51.88M
Income Before Nonrecurring Items1.61M--7.83M-10.26M--1.43M1.08M1.31M1.05M
Income from Nonrecurring Items----------
Yew Bio Pharm Earnings Per Share Basic Net
0.030.00-0.150.010.200.00-0.030.020.030.02
Yew Bio Pharm Earnings Per Share Diluted Net
0.030.00-0.150.010.190.00-0.030.020.030.02
EPS Diluted Before Nonrecurring Items0.030.00-0.150.010.190.00-0.030.020.030.02
Preferred Dividends Acc Pd----------
Dividends Common0.000.000.00-------
Dividend Per Share Common0.000.000.000.000.000.000.000.000.000.00
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

Yew Bio Pharm stock analysis involves checking at least a few of the important things like:

  • Revenue: This is the inflow that is generated from the sale of goods or services and is $14.82M for this quarter of 2018 Q2. Our Yew Bio Pharm revenue chart gives a clear visual representation of how the topline or sales growth has been. Investors often invest only in those companies where the revenue is growing at a steady rate.
  • Bottom line: This refers to the last line in a profit and loss statement and denotes the net profit or loss for a particular period. The figure currently stands at $1.61M for Yew Bio Pharm for 2018 Q2. This figure is arrived at after deducting all operating expenses, interest, and taxes from revenue.

The income statement is also called the profit and loss statement. Apart from the YEWB income statement, one can check the Yew Bio Pharm historical stock prices to check how the price has moved with time.

Yew Bio Pharm Income Statement - Key Financial Ratios

PS Ratio (price sales ratio)
0.3
Operating Margin
14
Net Profit Margin
10.9
Dividend Yield
0%